Economic Evaluation For Fluvestrant 500 Mg Im Versus Exemestene In Egyptian Patients With Metastatic Breast Cancer
Nov 1, 2015, 00:00 AM
10.1016/j.jval.2015.09.1192
https://www.valueinhealthjournal.com/article/S1098-3015(15)03268-4/fulltext
Section Title :
Research Podium Presentations - Session 1 and Session 2
Section Order :
692
First Page :
A461
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03268-4&doi=10.1016/j.jval.2015.09.1192